Journal of Veterinary Internal Medicine (Mar 2021)

Clinical performance of a point‐of‐care Coccidioides antibody test in dogs

  • Krystle L. Reagan,
  • Ian McHardy,
  • George R. Thompson III,
  • Jane E. Sykes

DOI
https://doi.org/10.1111/jvim.16087
Journal volume & issue
Vol. 35, no. 2
pp. 965 – 969

Abstract

Read online

Abstract Background Point‐of‐care (POC) Coccidioides antibody assays may provide veterinarians with rapid and accurate diagnostic information. Objectives To determine the agreement of a POC lateral flow assay (LFA), sona Coccidioides (IMMY, Norman, Oklahoma) with the current diagnostic standard, the immunodiffusion assay (agar gel immunodiffusion [AGID]; Coccidioidomycosis Serology Laboratory, University of California, Davis, California). Animals Forty‐eight sera specimens from 48 dogs. Methods Sera specimens were collected from client‐owned dogs that had a clinical suspicion for coccidioidomycosis. Animals were classified as Coccidioides antibody‐positive (n = 36) based on a positive AGID or Coccidioides antibody‐negative (n = 12) based on a negative AGID. The performance of the LFA assay was determined by comparing results to AGID results. Results The LFA assay demonstrated agreement in 32 of 36 Coccidioides antibody‐positive specimens and 12 of 12 Coccidioides antibody‐negative specimens, resulting in a positive percentage agreement of 88.9% (95% confidence interval [CI], 74.7‐95.6%) and negative percentage agreement of 100% (95% CI, 75.8‐100%) as compared to AGID. A receiver operator characteristic curve was constructed, and the area under the curve was 0.944 (CI, 0.880‐1.000). Conclusion and Clinical importance This LFA is a rapid alternative to the traditional AGID. The LFA provides excellent predictive value for positive results. Positive agreement was lower in dogs with low AGID titers; therefore, confirmatory testing is recommended if a high index of suspicion exists.

Keywords